BCAB
BioAtla Inc

1,337
Mkt Cap
$40.99M
Volume
455,873.00
52W High
$2.53
52W Low
$0.24
PE Ratio
-0.63
BCAB Fundamentals
Price
$0.6948
Prev Close
$0.698
Open
$0.6929
50D MA
$0.6543
Beta
1.84
Avg. Volume
1.01M
EPS (Annual)
-$1.44
P/B
-2.45
Rev/Employee
$144,736.84
Loading...
Loading...
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
76

Frequently Asked Questions

What is Market Cap of BioAtla Inc?
What is the 52-week high for BioAtla Inc?
What is the 52-week low for BioAtla Inc?
What is BioAtla Inc stock price today?
What was BioAtla Inc stock price yesterday?
What is the PE ratio of BioAtla Inc?
What is the Price-to-Book ratio of BioAtla Inc?
What is the 50-day moving average of BioAtla Inc?
How many employess does BioAtla Inc has?

Latest BCAB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.